Angel News

Angel News

Back to Homepage

10th May 2018

Synthetic antibody firm secures £1.5m investment from Mercia

An East Midlands life sciences company which develops synthetic alternatives to antibodies has closed a £1.5m Series A funding round supported by Mercia Fund Managers and a number of private investors.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage